178 related articles for article (PubMed ID: 8445170)
1. Neurofibromatosis type 1: magnetic resonance imaging findings.
DiMario FJ; Ramsby G; Greenstein R; Langshur S; Dunham B
J Child Neurol; 1993 Jan; 8(1):32-9. PubMed ID: 8445170
[TBL] [Abstract][Full Text] [Related]
2. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
Magnaldi S; White RM; Bryan RN
Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
[TBL] [Abstract][Full Text] [Related]
3. A new sign of neurofibromatosis on magnetic resonance imaging of children.
Goldstein SM; Curless RG; Donovan Post MJ; Quencer RM
Arch Neurol; 1989 Nov; 46(11):1222-4. PubMed ID: 2510704
[TBL] [Abstract][Full Text] [Related]
4. [The MR tomographic findings in cranial manifestations of neurofibromatosis].
Vestring T; Fahrendorf G; Bongartz G; Reuther G; Peters PE
Rofo; 1990 Dec; 153(6):678-82. PubMed ID: 2176321
[TBL] [Abstract][Full Text] [Related]
5. Cranial MR imaging in patients with von Recklinghausen's disease (neurofibromatosis type I).
Hashimoto T; Tayama M; Miyazaki M; Kuroda Y; Hiura K; Hujino K; Yamashita K
Neuropediatrics; 1990 Nov; 21(4):193-8. PubMed ID: 2127081
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis types 1 and 2: cranial MR findings.
Aoki S; Barkovich AJ; Nishimura K; Kjos BO; Machida T; Cogen P; Edwards M; Norman D
Radiology; 1989 Aug; 172(2):527-34. PubMed ID: 2501822
[TBL] [Abstract][Full Text] [Related]
7. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
[TBL] [Abstract][Full Text] [Related]
8. Cranial MR imaging in neurofibromatosis.
Bognanno JR; Edwards MK; Lee TA; Dunn DW; Roos KL; Klatte EC
AJR Am J Roentgenol; 1988 Aug; 151(2):381-8. PubMed ID: 3134807
[TBL] [Abstract][Full Text] [Related]
9. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
10. Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1.
Raininko R; Thelin L; Eeg-Olofsson O
Neuropediatrics; 2001 Oct; 32(5):225-30. PubMed ID: 11748492
[TBL] [Abstract][Full Text] [Related]
11. CT detection of basal ganglion lesions in neurofibromatosis type 1: correlation with MRI.
Menor F; Marti-Bonmatí L
Neuroradiology; 1992; 34(4):305-7. PubMed ID: 1528439
[TBL] [Abstract][Full Text] [Related]
12. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.
DiPaolo DP; Zimmerman RA; Rorke LB; Zackai EH; Bilaniuk LT; Yachnis AT
Radiology; 1995 Jun; 195(3):721-4. PubMed ID: 7754001
[TBL] [Abstract][Full Text] [Related]
14. Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1.
Margari L; Presicci A; Ventura P; Maria Bacca S; Iliceto G; Medicamento N; Buttiglione M; Perniola T
J Child Neurol; 2006 Dec; 21(12):1085-90. PubMed ID: 17156707
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.
Menor F; Marti-Bonmati L; Arana E; Poyatos C; Cortina H
Eur J Radiol; 1998 Jan; 26(2):121-31. PubMed ID: 9518221
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
[TBL] [Abstract][Full Text] [Related]
17. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
[TBL] [Abstract][Full Text] [Related]
18. [Spontaneous regression of basal ganglia lesions in a case of neurofibromatosis type 1 (case report)].
Oztürk M; Ozyazgan I; Mavili E; Orhan S
Tani Girisim Radyol; 2003 Dec; 9(4):439-42. PubMed ID: 14730952
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.
Balestri P; Calistri L; Vivarelli R; Bartalini G; Mancini L; Berardi A; Fois A
Childs Nerv Syst; 1993 Dec; 9(8):448-51. PubMed ID: 8124670
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities.
Itoh T; Magnaldi S; White RM; Denckla MB; Hofman K; Naidu S; Bryan RN
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1513-9. PubMed ID: 7985572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
